New diabetes clinical trial: A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension

Published on: October 17, 2024 at 11:00PM
Conditions: Type 2 Diabetes; Hypertension
Interventions: Drug: THP-00101; Drug: THP-00102; Drug: THP-00103; Drug: THP-00104; Drug: THP-00105; Drug: THP-00106
Sponsors: THPharm Corp.
Not yet recruiting
https://ift.tt/Nkmq0sF